Jane Street Group, LLC Gritstone Bio, Inc. Call Options Transaction History

Jane Street Group, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$4.03 - $12.19 $93,093 - $281,589	-23,100 Reduced 25.93%	66,000 $272,000
Q4 2021 Feb 15, 2022	SELL	$8.76 - $13.71 $40,296 - $63,066	-4,600 Reduced 4.91%	89,100 $1.15 Million
Q3 2021 Nov 16, 2021	BUY	$6.41 - $13.54 $600,617 - $1.27 Million	93,700 New	93,700 $1.01 Million

17.8M

68.3K

59.8K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.